期刊文献+

Effect Comparison of different formulation of Dang-Gui-Bu-Xu-Tang on myelosuppression mouse 被引量:9

Effect Comparison of different formulation of Dang-Gui-Bu-Xu-Tang on myelosuppression mouse
在线阅读 下载PDF
导出
摘要 Objective: To compare effect of different formulation of Dang-Gui-Bu-Xu-Tang(DCBXT) on myelosuppression mouse. Methods: HPLC was used to measure active ingredients of two DCBXT formulations. Hemopoesic function of bone marrow was measured by hemopoietic progenitor cell culture and peipheral blood count. And hemopoietic factors in bone marrow were tested by ELISA. Results: The content level of astragaloside A in granule formulation was higher than that in decoction and the content ratio of active ingredient was close to 5 : 1. Two DGBXD formulations could significantly improve amount of peripheral blood cells, and bone marrow cells of bone marrow suppression mice (P < 0.05). DGBXD granule formulation significantly increased the colony quantity of all progenitor cell lines and amount of G(2)/M and S phase cells (P < 0.05). It also significantly decreased amount of G(0)/G(1) phase cells in the bone marrow and was more effective (P < 0.05). Conclusions: DGBXT decoction and the granule formulation all can improve the hematopoietic function of bone marrow suppression mouse. They can improve quantities of peripheral blood and nucleated bone marrow cells, and yield of the hematopoietic stem/progenitor cells in vitro colony; balance the expression of cytokine (EPO, TPO and GM-CSF) in bone marrow microenvirement. They can also facilitate hematopoietic stem/progenitor cells to enter the cell cycle. And the effect of granule formulation is more satisfactory. Objective:To compare effect of different formulation of Dang-Gui-Bu-Xu-Tang(DCBXT) on myelosuppression mouse.Methods:HPLC was used to measure active ingredients of two DGBXT formulations,Hemopoesic function of bone marrow was measured by hemopoietic progenitor cell culture and peipheral blood count.And hemopoietic factors in bone marrow were tested by ELISA.Results:The content level of astragaloside A in granule formulation was higher than that in decoction and the content ratio of active ingredient was close to 5:1.Two DGBXD formulations could significantly improve amount of peripheral blood cells,and bone marrow cells of bone marrow suppression mice(P&lt;0.05).DGBXD granule formulation significantly increased the colony quantity of all progenitor cell lines and amount of G<sub>2</sub>/M and S phase cells(P&lt;0.05). It also significantly decreased amount of G<sub>0</sub>/G<sub>1</sub> phase cells in the bone marrow and was more effective(P&lt;0.05).Conclusions:DGBXT decoction and the granule formulation all can improve the hematopoietic function of bone marrow suppression mouse.They can improve quantities of peripheral blood and nucleated bone marrow cells,and yield of the hematopoietic stem/progenitor cells in vitro colony;balance the expression of cytokine(EPO,TPO and GM-GSF) in bone marrow microenvirement.They can also facilitate hematopoietic stem/progenitor cells to enter the cell cycle.And the effect of granule formulation is more satisfactory.
出处 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2011年第7期556-559,共4页 亚太热带医药杂志(英文版)
基金 the Sanjiu Modern Medicine Ltd.for providing fund and DGBXT granule formula
  • 相关文献

参考文献2

二级参考文献16

  • 1刘文君,刘斌,郭渠莲,张迎春,袁亚杰,付晓冬,邓正华,林江.更昔洛韦和黄芪对巨细胞病毒感染所致造血祖细胞增殖抑制的影响[J].中华儿科杂志,2004,42(7):490-494. 被引量:23
  • 2Caver J,Middleton P G,Segall M,et al.Recipient TNF-α and IL-10 gene polemorphisms associate with early mortality and acute GVHD severity in HLA matched sibling BMT[J].Blood,1999,94(7):3641-3946.
  • 3Lin M T,Storer B,Martin P J,et al.Ralation of an interleukn-10 prom other polyorphism to grart-versus-host disease and survival after hem atopoietic-cell transpiantation[J].N Engl J Med,2003,349(9):2201-2210.
  • 4Robin M,Porcher R,De Lastro A R,et al.Disk factors for late infections after allogeneic homatopietic stem cell transplantation form a matched related donor[J].Bio Blood Marrow Transplant,2007,13(4):1304-1312.
  • 5Sarmiento J,Rodrigez-Molina J,Fernandez-Yanez J,et al.IgG monitoring to identify the risk for development of infection in heart transplant recipients[J].Transpl Infect Dis,2006,8(1):49-53.
  • 6Einsls H,Hebart H,Kauffmann Schneider C,et al.Risk facters for treatment failures in patients receiving PCR based preemptive therapy for CMV infection[J].Bone Marrow Transplant,2000,25(13):757-763.
  • 7Navalpotro D,Gimeno C,Navarro D.PCR detection of viral DNA in serum as an ancillary analysis for the dignosis of acute mononucleosis-like syndrome due to human cytomega-lovirus(HCMV)in immunocompetent patients[J].J Clin Virol,2005,35(2):193-196.
  • 8Van der Bij W,Speich R.Management of cytomegalovirus infection and disease after solid-organ transplantion[J].Clin Infect Dis,2001,33(1):33-37.
  • 9Dubousky J,Daxberger W,Fritsch G,et al.Kinetics of chimerism during the early post-transpiant period in pediatric patients with malingenant and nonmalingnant hematologic disorders:implications for timely detection of engraftment,graft failure and rejection[J].Leukemia,1999,13:2059-2069.
  • 10刘开彦.造血干细胞移植患者巨细胞病毒感染的诊治进展[J].中国实用内科杂志,2007,27(20):1597-1598. 被引量:9

共引文献9

同被引文献79

引证文献9

二级引证文献135

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部